Literature DB >> 731870

A study on the effects of nifedipine in hypertensive crises and severe hypertension.

I Kuwajima, K Ueda, C Kamata, S Matsushita, K Kuramoto, M Murakami, Y Hada.   

Abstract

Ten mg of Nifedipine, a Ca++ antagonist, was administered orally in 2 groups of patients; Group 1: 6 patients in hypertensive emergency and Group II: 12 patients with intractable, severe hypertension. Following results were obtained. 1) A marked hypotensive effect was observed in all patients of Group I. The maximum effect was observed within 30 to 60 min and lasted for approximately 180 min. Clinical symptoms also improved remarkably with the fall in blood pressure. Any side effect was not observed. 2) A marked hypotensive effect was observed in all cases of Group II. The blood pressure fell by 21.4% systolic (p less than 0.01) and 19.4% diastolic (p less than 0.02). The peripheral vascular resistance also showed the decrease by 26.2% (p less than 0.01). The heart rate and cardiac index increased slightly. It was suggested that the hypotensive mechanism of this preparation is due primarily to the peripheral vasodilation.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 731870     DOI: 10.1536/ihj.19.455

Source DB:  PubMed          Journal:  Jpn Heart J        ISSN: 0021-4868


  14 in total

Review 1.  Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders.

Authors:  E M Sorkin; S P Clissold; R N Brogden
Journal:  Drugs       Date:  1985-09       Impact factor: 9.546

Review 2.  Calcium antagonists. Clinical use in the treatment of systemic hypertension.

Authors:  C Spivack; S Ocken; W H Frishman
Journal:  Drugs       Date:  1983-02       Impact factor: 9.546

Review 3.  Vasodilators.

Authors:  T T Zsotér
Journal:  Can Med Assoc J       Date:  1983-09-01       Impact factor: 8.262

4.  The effects of nifedipine and hydralazine induced hypotension on sympathetic activity.

Authors:  M B Murphy; A J Scriven; M J Brown; R Causon; C T Dollery
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

5.  Nifedipine attenuates the hypertensive response to tracheal intubation in pregnancy-induced hypertension.

Authors:  N Kumar; Y K Batra; I Bala; S Gopalan
Journal:  Can J Anaesth       Date:  1993-04       Impact factor: 5.063

Review 6.  Drug therapy of renovascular hypertension.

Authors:  Talma Rosenthal
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546

7.  The Role of a Single Dose of Sublingual Nifedipine in Managing Hypertensive Emergencies in the Patients who Undergo Haemodialysis.

Authors:  Jagjit Singh; Rajiv Kumar; Vitul K Gupta; Arun Kumar Maria; Rubina Paul; Simerpreet Kaur; Prabhnoor Singh Hayer
Journal:  J Clin Diagn Res       Date:  2012-12-15

Review 8.  Treatment of severe hypertension and hypertensive crises with nifedipine.

Authors:  M C Houston
Journal:  West J Med       Date:  1987-06

9.  Effect of verapamil on blood pressure and lesions in heart and kidney of rats made hypertensive by deoxycorticosterone (DOC).

Authors:  A P Aguas; P A Nickerson
Journal:  Am J Pathol       Date:  1983-01       Impact factor: 4.307

Review 10.  Calcium antagonists. Pharmacodynamic effects and mechanism of action.

Authors:  T T Zsotér; J G Church
Journal:  Drugs       Date:  1983-02       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.